课题基金 / 基金详情

Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection

Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection
用于早期发现登革热感染的快速护理点诊断
批准号:
8905431
负责人:
HyunDae Cho
金额:
$30.52万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-20 至 2017-02-19

项目摘要

项目成果

HyunDae Cho的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Rapid Point-of-Care Diagnostic for Early Detection of Dengue Infection Cross Life Technologies Inc. Dengue viruses (DENV) are one of the most dangerous and significant pathogens in the world, and there are 230 million cases of dengue virus infections per year, mostly in Latin America and Southeast Asia. These mosquito-borne viruses cause periodic explosive epidemics in many tropical and sub-tropical countries. Cross Life technologies' dengue diagnostic is being developed to detect dengue infection early so that patients can be treated effectively. Early and rapid detection of dengue virus (DENV) infection during the febrile period is crucial for proper patient management and containment of the disease. However, current methods for early detection of dengue involve the use of RT-PCR instruments in the laboratory, which may not be available in areas where dengue is endemic, and which may be too slow. Cross Life Technologies (CLT) proposes to develop a Template Assisted Rapid Assay (TARA) diagnostics for detection of dengue viruses in human blood. TARA dengue diagnostic will detect dengue in 15 minutes on a paper strip at the point-of-care (POC) so that patients can be treated rapidly and at low cost. A sensitive nucleic acid POC diagnostic paper dipstick device capable of detecting and identifying the 4 serotypes of dengue virus will be developed in order to facilitate more accurate detection of dengue infection in order to improve public health. We propose the development of a multiplex dengue diagnostic assay using an innovative RNA amplification chemistry. This innovative technology will provide an enzyme-free, PCR-less, instrumentation-free, low-cost, disposable, rapid and sensitive POC dengue diagnostics directly from whole blood samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
  • 批准号:
    10896570
  • 项目类别:
  • 资助金额:
    $99.4万
  • 财政年份:
    2023
  • 负责人:
    HyunDae Cho
  • 依托单位:
Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
  • 批准号:
    10010422
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2020
  • 负责人:
    HyunDae Cho
  • 依托单位:
Rapid Point-of-Care RNA Diagnostic for Dengue Infection
  • 批准号:
    10436535
  • 项目类别:
  • 资助金额:
    $99.98万
  • 财政年份:
    2019
  • 负责人:
    HyunDae Cho
  • 依托单位:
A Rapid HIV RNA Detection without Sample Preparation
  • 批准号:
    10017696
  • 项目类别:
  • 资助金额:
    $48.97万
  • 财政年份:
    2019
  • 负责人:
    HyunDae Cho
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: